$TMCI

$4.55 +$0.13 (2.94%) Close

$TMCI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 65.0M shares outstanding

Who owns TMCI?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 129.1%

Treace John T. 52.7% · Samsara Biocapital, LLC 15.9%

Institutional ownership

100.0%

0 pts vs last qtr

Institutional holders

151

-17 vs last qtr

Net shares bought

−2.5M

by institutions in Q2 2026

New / sold out

27 / 44

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Polar Asset Management Partners Inc. NEW +2.3M
Samsara Biocapital, LLC +1.9M

Biggest sellers in Q2 2026

SymBiosis Capital Partners, LLC SOLD OUT −3.7M
BlackRock, Inc. −2.2M

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Treace Medical Concepts, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2020–FY2025

+70.7%

+11.28% a year

Each share's claim on the business

−41.4%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $94.2M

over 6 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years24% 3–5 years4% 1–3 years17% Under 1 year56%

Quarterly turnover

16.4%

of institutional shares changed hands

Top 10 managers, median time held

2 quarters

Super Investors

Investment managers reporting TMCI on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
SB Samsara Biocapital, LLC	10.4M	15.94%	+1.9M (+22.0%)	Q4 '25	0.7%
Shares held by quarter Peak holding10.4M (Q2'26) Change over 8 quarters+10.4M Share of the company15.940% Samsara Biocapital, LLC's full portfolio →
RC Ra Capital Management, L.P.	8.5M	13.07%	Unchanged	Q4 '25	0.1%
Shares held by quarter Peak holding8.5M (Q4'25) Change over 8 quarters+8.5M Share of the company13.070% Ra Capital Management, L.P.'s full portfolio →

Samsara Biocapital, LLC

10.4M

% of company

15.94%

Change vs last qtr

+1.9M (+22.0%)

Held since

Q4 '25

Ra Capital Management, L.P.

8.5M

% of company

13.07%

Change vs last qtr

Unchanged

Held since

Q4 '25

28 more super investors behind a free account

See every manager holding Treace Medical Concepts, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting TMCI on Form N-PORT; together they hold 18.3% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$8.53M	5.1M	7.83%	0.00%	June 30, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$2.81M	1.4M	2.12%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$8.53M

% of company

7.83%

% of the fund

0.00%

As of

June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$2.81M

% of company

2.12%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Treace Medical Concepts, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
TJ Treace John T. Insider	34.3M	52.67%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company52.670% Treace John T.'s insider activity →
MR Mott Richard W Insider	1.6M	2.51%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company2.510% Mott Richard W's insider activity →

Treace John T.

Insider

34.3M

% of company

52.67%

Change vs last qtr

—

Held since

—

Mott Richard W

Insider

1.6M

% of company

2.51%

Change vs last qtr

—

Held since

—

11 more holders behind a free account

See every insider and 5%+ holder of Treace Medical Concepts, Inc..

Comments